dr amanda kerr
Amanda Kerr joined CTSU as a research assistant with the Early Breast Cancer Trialists’ Collaborative Group in 2008. She went on to complete a PhD with Sarah Darby, investigating the cardiotoxic effects of anthracycline chemotherapy, graduating in 2016. Amanda works in the Late Effects team working on systematic reviews of long term outcomes of cancer treatments.
Adjuvant and neoadjuvant breast cancer treatments: A systematic review of their effects on mortality.
Kerr AJ. et al, (2022), Cancer Treat Rev, 105
Exposure of the oesophagus in breast cancer radiotherapy: A systematic review of oesophagus doses published 2010-2020.
Duane FK. et al, (2021), Radiother Oncol